Staging of Bisphosphonate-Related Osteonecrosis of the Jaws Inpatients with Malignant Tumors according multislice Computed Tomography
Abstract
About the Author
Natalia Aleksandrovna ZhukovaRussian Federation
References
1. Заславская Н.А. (Жукова Н.А.), Дробышев А.Ю., Лежнев Д.А. Диагностика и лечение остеонерозов челюстей у больных злокачественными новообразованиями, получающих терапию антирезорбтивными препаратами (бисфосфонаты, деносумаб). Вестник МВД. 2014; 1: 14-16.
2. Заславская Н.А. (Жукова Н.А.) Оптимизация профилактики и лечения бисфосонатных остеонекрозов челюстей у больных со злокачественными новообразованиями: Дис.. канд. мед. наук. М., 2014. 166 c.
3. Kumar V., Shahi A.K. Nitrogen containing bisphosphonates associated osteonecrosis of the jaws: A review for past 10 year literature. Dent. Res. J. (Isfahan). 2014; 11: 147-153.
4. Khan A.A., Morrison A., Hanley D.A. et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015; 30: 3-23.
5. Манзюк Л.В., Османова Л.И., Снеговой А.В. Зомета в лечении костных метастазов и нарушений минерального обмена у онкологических больных. Русский медицинский журнал. Онкология. 2007; 25: 1924-1933.
6. Заславская Н.А. (Жукова Н.А.), Дробышев А.Ю., Волков А.В. Опыт лечения остеонекрозов челюстей у пациентов, получающих антирезорбтивную терапию (бисфосфонаты, “Деносумаб”). Cathedra. 2014; 47: 32-34.
7. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J. Oral. Max. Surg. 2003; 61: 1115-1117.
8. Ruggiero S.L., Fantasia J., Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelienes for diagnosis, staging and management. Oral. Gurg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 2006; 102: 433-441.
9. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. J. Oral. Maxillofac. Surg. 2007; 65: 369-376.
10. Ruggiero S.L., Dodson T.B., Assael L.A. et al. B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws - 2009 Update. J. Oral. Maxillofac. Surg. 2009; 67: 2-12.
11. McMahon R.E., Bouquot J.E., Glueck C.J. et al. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease. J. Oral. Maxillofac. Surg. 2007; 65:1899-1900.
12. Mawardi H., Treister N., Richardson P. et al. Sinus tracts - an early sign of bisphosphonate-related osteonecrosis of the jaws? J. Oral. Maxillofac. Surg. 2009; 67: 593-601.
13. Bagan J.V., Jimenez Y., Diaz J.M. et al. Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification. Oral. Oncol. 2009; 45:645-646.
14. Bedogni A., Fusco V., Agrillo A., Campisi G. Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaws (BRONJ). Oral. Dis. 2012; 18: 621-623.
15. Ruggiero S.L., Dodson T.B, Fantasia J. et al. American Association of Oral and Maxillofacial Surgeons Position Paper on medical-related osteonecrosis of the jaw - 2014 update. J. Oral. Maxillofac. Surg. 2014; 72: 1938-1956.
Review
For citations:
Zhukova N.A. Staging of Bisphosphonate-Related Osteonecrosis of the Jaws Inpatients with Malignant Tumors according multislice Computed Tomography. Medical Visualization. 2016;(3):17-27. (In Russ.)